How much is the Krabbe Disease Treatment Market market?

The krabbe disease treatment market market size is estimated to grow at $$ 405.4 mn in 2023. Read More

What is the growth rate of the Krabbe Disease Treatment Market market?

The growth rate of the krabbe disease treatment market year-over-year is 7.08%. Read More

Which region held the largest market share in the Krabbe Disease Treatment Market market?

North America is the region to held the largest market share with 31% growth. Read More

Who are the key players in the Krabbe Disease Treatment Market market?

AbbVie Inc., Acorda Therapeutics Inc., CENTOGENE NV, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Novartis AG, Pfizer Inc., Polaryx, Teva Pharmaceutical Industries Ltd., UCB SA .... Read More

Which Segment has the largest market share in the Krabbe Disease Treatment Market market?

Therapy is the segment that has the largest market share in the market. Read More

Krabbe Disease Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, Japan - Size and Forecast 2024-2028

Published: Jun 2024
Pages: 145
SKU: IRTNTR73314

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Krabbe Disease Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Krabbe Disease Treatment Market 2018 - 2022 ($ million)

4.2 Therapy segment analysis 2018 - 2022
- Historic Market Size - Therapy Segment 2018 - 2022 ($ million)

4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy

6.1 Market segments
- Chart on Therapy - Market share 2023-2028 (%)
- Data Table on Therapy - Market share 2023-2028 (%)

6.2 Comparison by Therapy
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy

6.3 Anticonvulsants - Market size and forecast 2023-2028
- Chart on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
- Data Table on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
- Chart on Anticonvulsants - Year-over-year growth 2023-2028 (%)
- Data Table on Anticonvulsants - Year-over-year growth 2023-2028 (%)

6.4 Muscle relaxants - Market size and forecast 2023-2028
- Chart on Muscle relaxants - Market size and forecast 2023-2028 ($ million)
- Data Table on Muscle relaxants - Market size and forecast 2023-2028 ($ million)
- Chart on Muscle relaxants - Year-over-year growth 2023-2028 (%)
- Data Table on Muscle relaxants - Year-over-year growth 2023-2028 (%)

6.5 HSCT - Market size and forecast 2023-2028
- Chart on HSCT - Market size and forecast 2023-2028 ($ million)
- Data Table on HSCT - Market size and forecast 2023-2028 ($ million)
- Chart on HSCT - Year-over-year growth 2023-2028 (%)
- Data Table on HSCT - Year-over-year growth 2023-2028 (%)

6.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)

6.7 Market opportunity by Therapy
- Market opportunity by Therapy ($ million)
- Data Table on Market opportunity by Therapy ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

8.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

8.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

8.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

8.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)

8.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers

9.2 Market challenges

9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview

10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

10.3 Landscape disruption
- Overview on factors of disruption

10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered

11.2 Market positioning of companies
- Matrix on companies position and classification

11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings

11.4 Acorda Therapeutics Inc.
- Acorda Therapeutics Inc. - Overview
- Acorda Therapeutics Inc. - Product / Service
- Acorda Therapeutics Inc. - Key offerings

11.5 CENTOGENE NV
- CENTOGENE NV - Overview
- CENTOGENE NV - Product / Service
- CENTOGENE NV - Key offerings

11.6 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus

11.7 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus

11.8 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus

11.9 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings

11.10 Polaryx
- Polaryx - Overview
- Polaryx - Product / Service
- Polaryx - Key offerings

11.11 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus